→
STERIS plc's current price of $212.11 reflects a decline of 1.79% from the previous close of $215.98, with a market cap of $20.80B. Despite a robust EPS growth of 52.18% YoY, the recent earnings misses indicate potential volatility ahead, warranting a neutral outlook.
Investors should adopt a cautious approach, holding STERIS shares until clearer performance indicators emerge post-earnings adjustments.
If STERIS can leverage its strong EPS growth of 52.18% and stabilize its revenue growth of 7.96%, it could regain investor confidence and move closer to its 52-week high of $269.44. Analysts have a consensus of 3 Strong Buy and 7 Buy ratings, indicating optimism around its long-term performance.
The recent earnings misses in Q4 and Q3 2026, where actual EPS fell short of estimates by $0.0467 and $0.0278 respectively, suggest potential operational challenges that could hinder growth. With the stock trading significantly below its 52-week high, further price declines may occur if performance does not improve.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates STE as Neutral. Investors should adopt a cautious approach, holding STERIS shares until clearer performance indicators emerge post-earnings adjustments.
The recent earnings misses in Q4 and Q3 2026, where actual EPS fell short of estimates by $0.0467 and $0.0278 respectively, suggest potential operational challenges that could hinder growth. With the stock trading significantly below its 52-week high, further price declines may occur if performance does not improve.
If STERIS can leverage its strong EPS growth of 52.18% and stabilize its revenue growth of 7.96%, it could regain investor confidence and move closer to its 52-week high of $269.44. Analysts have a consensus of 3 Strong Buy and 7 Buy ratings, indicating optimism around its long-term performance.
STERIS plc's current price of $212.11 reflects a decline of 1.79% from the previous close of $215.98, with a market cap of $20.80B. Despite a robust EPS growth of 52.18% YoY, the recent earnings misses indicate potential volatility ahead, warranting a neutral outlook.
STERIS plc's current price of $212.11 reflects a decline of 1.79% from the previous close of $215.98, with a market cap of $20.80B. Despite a robust EPS growth of 52.18% YoY, the recent earnings misses indicate potential volatility ahead, warranting a neutral outlook. Our overall verdict is Neutral.
Helm Terminal offers free AI-powered stock analysis for STE at helmterminal.dev/analyze/STE, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.